
Radiology in Israel
Comparing radiological practices in Israel with those of Europe and the USA, Professor Graif explained that his country combines both.
Comparing radiological practices in Israel with those of Europe and the USA, Professor Graif explained that his country combines both.
Visage PACS/CS, a scalable PACS solution based on web and thin client technology with fully integrated clinical applications, is to be demonstrated at this year's RSNA in Chicago, along with a comprehensive portfolio of life sciences products and services from Visage Imaging, a subsidiary of Mercury Computer Systems Inc.
The suppression of angiogenesis is an established procedure used to make a positive impact on tumour growth and the development of metastases - with varying success.
ulrich medical, established 25 years ago, is an independent medium-size medical technology firm with worldwide sales. Among its products are contrast agent injectors for contrast agents used in computer and magnetic resonance tomography.
Imaging water molecules in the brain correlates structural and functional deficits
In recent years molecular imaging has developed into a hot topic field in medical research, which raised high expectations.
Carestream's molecular imaging group focuses on life sciences, developing high-performance digital imaging systems, imaging agents, film and accessories for the research and drug discovery/development markets.
The term 'molecular medicine' has quickly become synonymous with brilliantly revealing images produced by innovative imaging techniques, new biomarkers and contrast agents. At Merck Research Laboratories (MRL) a team of researchers led by Dr Andrew Plump, the firm's Executive Director and Cardiovascular Disease Franchise Integrator, are seeking biomarkers for CVDs, and co-operating with Philips…
Medical imaging is a first order boom area.
Launching its newest Accutron series injector, Medtron AG proudly reports that the injector's high levels of accuracy, efficacy, and safety result from fifteen years' experience in development, the intensive research of the expert team, their close follow-up of imaging modalities and, finally, their experience in addressing end-user inputs and needs.
A comprehensive knowledge of the topographic relationships of anatomical structures is a must for all doctors.
X-ray based mammograms detect only 56% of early lesions in high risk women compared with 92% when MRI scanning (mostly used for brain scans), according to a study by Christiane Kuhl and colleagues at the University of Bonn (pub: the Lancet. 8/07).
Near-infrared fluorescence mammography works with rays of near-infrared (NIR) light instead of X-rays. Although this is thought to be a very promising technique, there have been no effective contrast agents.
What a difference a few days can make. The last week in September kicked off with more dire warnings about the potentially disastrous impact that the Physical Agents (Electromagnetic Fields) Directive 2004/40/EC will have on the use of MRI in clinical practice and medical research across the European Union (EU).
About 27,000 healthcare professionals from over 100 countries attended RSNA 2006. These included over 5,000 European clinicians. In addition, over 28,000 people from non-US countries manned about 750 exhibition stands.
In 2008, the European Congress of Radiology (ECR) will include a Special Focus Session titled "Women in Radiology". During an EH interview, Professor Dr Maximilian Reiser, President of ECR 2008 (Vienna, Austria) discussed this and other aspects of the new programme.
For women (or friends and relatives of women with breast cancer),
"If you think 53 makes you old enough to retire, then fine, go ahead and retire. But don't expect the state to pay for it." President Nicolas Sarkozy, during his election campaign
According to a study from the technology consultancy Frost & Sullivan the market for CT systems in Europe will grow annually by 4% - in 2013 sales will be worth $1.14 billion. Customers' primary request are cardiac imaging applications, but software innovations and improvements in scan time and image acquisition are also distinguishing features of next-generation systems.
The directive 2004/40/EC of the European Parliament sets minimum health and safety requirements regarding the exposure of workers to the risks arising from physical agents (electromagnetic fields). Too strict requirements, as the use of MRI in medical research and clinical practice throughout Europe is threatened. Now, it is expected that the directive is going to be modified and delayed for four…
Researchers from the School of Dentistry at the University of Manchester developed a technique to identify osteoporosis from ordinary dental x-rays. The software-based method has the potential to improve the early diagnoses of osteoporosis on a wide-scale screening level.
The Acuson P10 is a new portable ultrasound device, developed and manufactured by Siemens Medical Solutions. The new system in the size of a Blackberry embodies Point of Care Testing (POCT) abilities: It weighs a little more than 700 grams and could be used for earliest possible diagnostics in an intensive care unit, ambulance or medical helicopter, providing physicians with valuable information…
The Virtual Institute for Seven Tesla Applications (VISTA) is a partnership of several Dutch universities. To evaluate the benefit of ultrahigh-field MRI the first human 7.0T whole-body research scanner, supplied by Philips Medical Systems, was installed at the Leiden University Medical Center (LUMC). Roland Plasterk, the Durch minister of education, culture and science, attended at the opening…
Some of the medical procedures and equipment showcased and discussed at the MEDICA 2007 are sure to provide medical experts with plenty of discussion material. In cardiac diagnostic imaging a minor revolution is taking place, with ultrasound procedures increasing in significance. But innovation in x-ray methods is also continuing.
Coronary stents provide wall wrapping of dissection, prevent elastic recoil, and reduce restenosis after percutaneous transluminal coronary angioplasty. In addition, drug eluting stents loaded with antiproliferative agents inhibit intimal hyperplasia and offer a further reduction of restenosis.